<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Texas Healthcare %26 Bioscience Institute from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Texas Healthcare %26 Bioscience Institute news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 20:05:05 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Texas+Healthcare+%26+Bioscience+Institute" rel="self" type="application/rss+xml" />

	
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site Clinical Trial</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029205&amp;HITNO=0&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029205&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533029587%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029205&amp;HITNO=0&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029205&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533029587%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029733&amp;HITNO=1&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029733&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533247939%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029733&amp;HITNO=1&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029733&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533247939%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsBlaze:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site Clinical Trial ..</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029230&amp;HITNO=2&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029230&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533040679%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029230&amp;HITNO=2&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029230&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533040679%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site Clinical Trial</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029175&amp;HITNO=3&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029175&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533021340%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029175&amp;HITNO=3&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029175&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533021340%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site Clinical Trial</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029157&amp;HITNO=4&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029157&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533011088%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029157&amp;HITNO=4&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029157&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533011088%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Stockwatch:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029120&amp;HITNO=5&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029120&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533005110%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029120&amp;HITNO=5&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029120&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533005110%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Market Wire via MSN Money:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029117&amp;HITNO=6&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029117&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533004637%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029117&amp;HITNO=6&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029117&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533004637%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Market Wire:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site Clinical Trial</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029067&amp;HITNO=7&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029067&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532984968%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029067&amp;HITNO=7&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029067&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532984968%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>EuroInvestor.co.uk:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site Clinical Trial</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029180&amp;HITNO=8&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029180&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533022953%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029180&amp;HITNO=8&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029180&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533022953%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>INVO Bioscience Announces the National Institute of Health and World Health Organization Approval of a 3 Site Clinical Trial</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029442&amp;HITNO=9&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029442&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533143407%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029442&amp;HITNO=9&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029442&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533143407%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TradingMarkets:</description></item>
<item><title>Study suggests environmental factors play a significant role in the etiology of Crohn's disease</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024678&amp;HITNO=10&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024678&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529056064%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024678&amp;HITNO=10&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024678&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529056064%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Life Sciences: New life sciences study findings have been reported from Korea Research Institute of Bioscience and Biotechnology</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010505&amp;HITNO=11&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010505&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522491914%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010505&amp;HITNO=11&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010505&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522491914%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsRX:</description></item>
<item><title>Ironman Announces 70.3 U.S. Pro Championship and Title Sponsor</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4008615&amp;HITNO=12&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4008615&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521599490%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4008615&amp;HITNO=12&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4008615&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521599490%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Interest!ALERT:</description></item>
<item><title>New in BioScience</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4008697&amp;HITNO=13&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4008697&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521636108%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4008697&amp;HITNO=13&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4008697&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521636108%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>American Institute of Biological Sciences:</description></item>
<item><title>NeoMatrix, Novation sign new technology agreement</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002739&amp;HITNO=14&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002739&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519141481%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002739&amp;HITNO=14&amp;MSIZE=106&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Texas%20Healthcare%20%26%20Bioscience%20Institute&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002739&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519141481%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
</channel></rss>